155 related articles for article (PubMed ID: 37208923)
1. Expression of cytoskeleton-associated protein 4 is associated with poor prognosis and metastasis in nasopharyngeal carcinoma.
Cai M; Wu W; Deng S; Yang Q; Wu H; Wang H; Zhang J; Feng Q; Shao J; Zeng Y; Li J
Exp Biol Med (Maywood); 2023 Jun; 248(12):1085-1094. PubMed ID: 37208923
[TBL] [Abstract][Full Text] [Related]
2. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
[TBL] [Abstract][Full Text] [Related]
3. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
[TBL] [Abstract][Full Text] [Related]
4. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
[TBL] [Abstract][Full Text] [Related]
5. LncRNA UCA1 affects epithelial-mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells.
Han R; Chen S; Wang J; Zhao Y; Li G
Cell Cycle; 2019 Nov; 18(21):3044-3053. PubMed ID: 31537148
[No Abstract] [Full Text] [Related]
6. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.
He JY; Han P; Zhang Y; Liu YD; Song SJ; Feng GK; An Y; Zhou AJ; Wang HB; Yuan L; Lin ZR; Xia TL; Li MZ; Liu YM; Huang XM; Zhang H; Zhong Q
J Mol Med (Berl); 2018 Apr; 96(3-4):265-279. PubMed ID: 29327067
[TBL] [Abstract][Full Text] [Related]
8. IGF2BP3 promotes cell metastasis and is associated with poor patient survival in nasopharyngeal carcinoma.
Xu Y; Guo Z; Peng H; Guo L; Wang P
J Cell Mol Med; 2022 Jan; 26(2):410-421. PubMed ID: 34894048
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
10. Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression.
Zheng PC; Chen X; Zhu HW; Zheng W; Mao LH; Lin C; Liu JN; Zheng M
Cancer Sci; 2014 Jun; 105(6):630-8. PubMed ID: 24703594
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
Qian W; Ren Z; Lu X
Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
Luo W; Fang W; Li S; Yao K
Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
[TBL] [Abstract][Full Text] [Related]
13. Forkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma.
Ou-Yang L; Xiao SJ; Liu P; Yi SJ; Zhang XL; Ou-Yang S; Tan SK; Lei X
Mol Med Rep; 2015 Dec; 12(6):8003-9. PubMed ID: 26461269
[TBL] [Abstract][Full Text] [Related]
14. CPVL suppresses metastasis of nasopharyngeal carcinoma through inhibiting epithelial-mesenchymal transition.
Wang X; Chen L; Huang K; Lin Y; Hong Y; Lin Z
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16473-16488. PubMed ID: 37712963
[TBL] [Abstract][Full Text] [Related]
15. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
16. A novel oncogenic seRNA promotes nasopharyngeal carcinoma metastasis.
Tan Y; Jiang C; Jia Q; Wang J; Huang G; Tang F
Cell Death Dis; 2022 Apr; 13(4):401. PubMed ID: 35461306
[TBL] [Abstract][Full Text] [Related]
17. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β.
Zhao L; Lin L; Pan C; Shi M; Liao Y; Bin J; Liao W
Oncotarget; 2015; 6(12):9781-93. PubMed ID: 25909165
[TBL] [Abstract][Full Text] [Related]
18. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
19. miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
Luo Z; Zhang L; Li Z; Jiang C; Dai Y; Liu X; Zheng Y; Yu H; Xiang J; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):604-9. PubMed ID: 21873783
[TBL] [Abstract][Full Text] [Related]
20. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
